HomeCancerColorectal

Colorectal

Present Gene Screens Miss Many at Excessive Most cancers Threat: Examine

THURSDAY, July 19, 2024 (HealthDay Information) -- Pretty much as good as many genetic checks is likely to be, a deeper take a...

Exploring Unmet Must Optimize Neoadjuvant Remedy in Resectable CRC

Though neoadjuvant remedy is a possible strategy for sufferers with resectable colorectal most cancers (CRC), additional analysis might assist optimize therapy methods and...

Agenus (AGEN) Tanks on Colorectal Most cancers Research Interim Information

Shares of Agenus Inc. AGEN plunged 58.8% on Jul 18 after the corporate introduced the result of its end-of-phase II (EOP2) assembly with...

Mainz BioMed Seeks FDA Breakthrough Gadget Designation for Superior Colorectal Most cancers Check – Proactive Buyers USA

Mainz BioMed Seeks FDA Breakthrough Gadget Designation for Superior Colorectal Most cancers Check  Proactive Buyers USA

TAS102 and Regorafenib Present Synergistic Exercise In opposition to GI Cancers – DocWire Information

TAS102 and Regorafenib Present Synergistic Exercise In opposition to GI Cancers  DocWire Information

Hot Topics